Utah Medical Products, Inc. Announces Quarterly Dividend
Rhea-AI Summary
Utah Medical Products (Nasdaq:UTMD) has announced a quarterly cash dividend of $0.305 per share of common stock. The dividend will be payable on April 3, 2025, to stockholders of record at the close of business on March 14, 2025. This represents a 1.7% increase compared to the dividend declared in the same quarter of the previous year.
The company specializes in healthcare products for women and their babies, developing and manufacturing specialty medical devices that are recognized as standard equipment by clinicians in over 100 countries worldwide.
Positive
- Dividend increased by 1.7% year-over-year
- Quarterly dividend payment of $0.305 per share maintained
- Global market presence in over 100 countries
Negative
- None.
News Market Reaction
On the day this news was published, UTMD gained 0.10%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
SALT LAKE CITY, UT / ACCESS Newswire / February 4, 2025 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty cents ($.305) per share of common stock payable on April 3, 2025 to stockholders of record at the close of business on March 14, 2025. This is a
Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long-term outcomes for their patients. For more information about Utah Medical Products, Inc., visit UTMD's website at www.utahmed.com.
Contact: Brian Koopman
(801) 566-1200
SOURCE: Utah Medical Products, Inc.
View the original press release on ACCESS Newswire